Stockscreener 앱 받기
43.54
6.20%
-3.37
전일 마감가:
$46.91
열려 있는:
$45.32
하루 거래량:
6,609
Relative Volume:
0.67
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-4.58%
1개월 성능:
+8.78%
6개월 성능:
-31.58%
1년 성능:
-20.52%
1일 변동 폭
$43.50
$45.63
1주일 범위
$43.93
$47.96
52주 변동 폭
$33.77
$69.56
Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Company Profile
명칭
Proshares Ultra Nasdaq Biotechnology 2 X Shares
전화
804-276-1160
주소
4222 COX ROAD, SUITE 200, GLEN ALLEN
BIB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIB
Proshares Ultra Nasdaq Biotechnology 2 X Shares
|
43.50 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
275.99 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
560.86 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
563.51 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
220.24 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
482.27 | 124.43B | 0 | 0 | 0 | 0.00 |
Proshares Ultra Nasdaq Biotechnology 2 X Shares 주식(BIB)의 최신 뉴스
Best Stocks Under $50 Right Now - Benzinga
Best ETFs for Day Trading – Updated Lists and Statistics - Trade That Swing
Best Stocks Under $20 Right Now - Benzinga
ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Sees Large Drop in Short Interest - MarketBeat
ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) to Issue $0.13 Quarterly Dividend - MarketBeat
Short Interest in Alpha Technology Group Limited (NASDAQ:ATGL) Decreases By 17.1% - Defense World
ProShares UltraShort QQQ (NYSEARCA:QID) Stock Cross Above 200-Day Moving Average – Here’s What Happened - Defense World
Short Interest in AlphaTime Acquisition Corp (NASDAQ:ATMC) Decreases By 12.5% - Defense World
B. Riley Forecasts Strong Price Appreciation for Rigel Pharmaceuticals (NASDAQ:RIGL) Stock - Defense World
Short Interest in Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Expands By 21.3% - Defense World
VirnetX (NYSE:VHC) Stock Price Crosses Above 200-Day Moving Average – Should You Sell? - Defense World
Cloud Peak Energy (OTCMKTS:CLDPQ) Stock Price Passes Above 200 Day Moving Average – Time to Sell? - Defense World
MicroVision (NASDAQ:MVIS) Shares Pass Above 200 Day Moving Average – Here’s What Happened - Defense World
Pacific Drilling (OTCMKTS:PACDQ) Shares Pass Above 200 Day Moving Average – What’s Next? - Defense World
Helpport AI (NASDAQ:HPAI) Trading Down 4.8% – Here’s Why - Defense World
BranchOut Food Inc. (NASDAQ:BOF) Sees Large Increase in Short Interest - Defense World
Short Interest in Better Home & Finance Holding (NASDAQ:BETR) Declines By 12.5% - Defense World
Private Advisor Group LLC Sells 11,056 Shares of First Bank (NASDAQ:FRBA) - Defense World
Saratoga Resources (OTCMKTS:SARA) Share Price Crosses Above 200-Day Moving Average – Here’s What Happened - Defense World
Hull Tactical US ETF (NYSEARCA:HTUS) Shares Sold by Private Advisor Group LLC - Defense World
BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Short Interest Update - Defense World
Private Advisor Group LLC Grows Stock Holdings in JPMorgan BetaBuilders U.S. Aggregate Bond ETF (NYSEARCA:BBAG) - Defense World
ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Short Interest Update - Defense World
Short Interest in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Grows By 154.5% - Defense World
Global X Blockchain & Bitcoin Strategy ETF (NASDAQ:BITS) Short Interest Update - Defense World
Best-Performing Leveraged ETFs of Last Week - Nasdaq
ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Pass Above 50-Day Moving AverageWhat's Next? - MarketBeat
Why 3x ETFs Are Riskier Than You Might Think - Investopedia
Stock Market Movers Today • Top Gainers & Losers - Benzinga
DeepSeek AI Model Sends Shockwaves Through Nvidia, Slams ETFs - Benzinga
How to Invest in SPDR S&P Biotech ETF (XBI) - The Motley Fool
4 Aggressive ETF Strategies - Investopedia
UltraShort Bitcoin ETF Offering 2x Inverse Returns Sees Record Volume as BTC Holds Above $90K - Yahoo Finance
ProShares S&P Technology Dividend Aristocrats ETF (BATS:TDV) Stock Pass Above Two Hundred Day Moving Average – Here’s Why - Defense World
Top Performing Leveraged/Inverse ETFs: 11/17/2024 - ETF Trends
Top Tech ETFs Right Now - Benzinga
Best Inverse ETFs Of 2024 - Forbes
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Nasdaq
5 Best Leveraged ETFs of the First Nine Months of 2024 - Yahoo Finance
Brad Jacobs' QXO Eyes $9.4 Billion Rexel Takeover - Finimize
Semiconductor ETFs Take A Beating, Dragged Lower By Nvidia, AMD, and Broadcom Stocks - Yahoo Finance
Nvidia ETFs Split In Pre-Market After Jensen Huang-Led Chip Giant Exceeds Q2 Expectations - Benzinga
Best 2x Leveraged ETFs - Benzinga
UVXY: The VIX Is Too Low (BATS:UVXY) - Seeking Alpha
BITU May Be Too Risky At 2x Leverage - Seeking Alpha
5 Best-Performing Leveraged ETFs of 1H - Yahoo Finance
UGL: 2x Daily Returns On Gold, But Be Careful Of Cycle (NYSEARCA:UGL) - Seeking Alpha
How To Trade Biotech Stocks: Can These Three Tips Help You Make More Profits? - Investor's Business Daily
The 5 Best Healthcare ETFs of 2023 - ETF.com
Top Performing Leveraged/Inverse ETFs: 04/07/2024 - Nasdaq
ProShares Debuts 2X Leveraged/Inverse Bitcoin ETFs - Nasdaq
Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB) 재무 분석
Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.13%
0.01%
자본화:
|
볼륨(24시간):